Your browser doesn't support javascript.
loading
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052.
Palumbo, Philip J; Fogel, Jessica M; Hudelson, Sarah E; Wilson, Ethan A; Hart, Stephen; Hovind, Laura; Piwowar-Manning, Estelle; Wallis, Carole; Papathanasopoulos, Maria A; Morgado, Mariza G; Saravanan, Shanmugam; Tripathy, Srikanth; Eron, Joseph J; Gallant, Joel E; McCauley, Marybeth; Gamble, Theresa; Hosseinipour, Mina C; Kumarasamy, Nagalingeswaran; Hakim, James G; Pilotto, Jose H; Kumwenda, Johnstone; Akelo, Victor; Godbole, Sheela V; Santos, Breno R; Grinsztejn, Beatriz; Panchia, Ravindre; Chariyalertsak, Suwat; Makhema, Joseph; Badal-Faesen, Sharlaa; Chen, Ying Q; Cohen, Myron S; Eshleman, Susan H.
Afiliação
  • Palumbo PJ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Hudelson SE; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wilson EA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Hart S; Frontier Science and Technology Research Foundation, Amherst, NY.
  • Hovind L; Frontier Science and Technology Research Foundation, Amherst, NY.
  • Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wallis C; Specialty Molecular Division, Lancet Laboratories and BARC-SA, Johannesburg, South Africa.
  • Papathanasopoulos MA; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Morgado MG; Laboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
  • Saravanan S; Y. R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
  • Tripathy S; National Institute for Research in Tuberculosis, Chennai, India.
  • Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Gallant JE; Department of Specialty Services, Southwest CARE Center, Santa Fe, NM.
  • McCauley M; HPTN Leadership and Operations Center, FHI 360, Washington, DC.
  • Gamble T; HPTN Leadership and Operations Center, FHI 360, Durham, NC.
  • Hosseinipour MC; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Kumarasamy N; UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi.
  • Hakim JG; CART CRS, YRGCARE Medical Centre, VHS, Chennai, India.
  • Pilotto JH; Department of Medicine, University of Zimbabwe, Harare, Zimbabwe.
  • Kumwenda J; Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil.
  • Akelo V; College of Medicine-Johns Hopkins Project, Blantyre, Malawi.
  • Godbole SV; Kenya Medical Research Institute (KEMRI)-Centers for Disease Control (CDC), Kisumu, Kenya.
  • Santos BR; Department of Epidemiology and Biostatistics, National AIDS Research Institute (ICMR), Pune, India.
  • Grinsztejn B; Department of Infectious Diseases, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
  • Panchia R; Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil.
  • Chariyalertsak S; Perinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS, Soweto, South Africa.
  • Makhema J; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Badal-Faesen S; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Chen YQ; Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Cohen MS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Eshleman SH; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
J Acquir Immune Defic Syndr ; 77(5): 484-491, 2018 04 15.
Article em En | MEDLINE | ID: mdl-29293156

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV / Farmacorresistência Viral / Antirretrovirais / Prevenção Secundária / Tempo para o Tratamento Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Moldávia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV / Farmacorresistência Viral / Antirretrovirais / Prevenção Secundária / Tempo para o Tratamento Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Moldávia